← All organizations

National Institute for Tuberculosis and Lung Diseases, Poland

Academic/HospitalWebsite ↗

Also known as: National Institute for Tuberculosis and Lung Diseases, Poland

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Aug 1, 2019

Timeline

1950s

Mar 10, 1951
National Institute for Tuberculosis and Lung Diseases, Poland— Founded

Drugs by trial phase (6 distinct, 4 trials)

Phase 4 (5 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

budesonide

Indications

Studied for

Recent trials (9)

NCT04036721Lead sponsorPhase 4Aug 1, 2019
NCT04036721Reponsible party - principal investigatorPhase 4Aug 1, 2019
NCT03393702Study directorPhase 4May 9, 2017
NCT03393702Reponsible party - principal investigatorPhase 4May 9, 2017
NCT03393702Lead sponsorPhase 4May 9, 2017
NCT03788057Lead sponsorN/AFeb 1, 2016
NCT03444636Study directorPhase 4Mar 2, 2015
NCT03444636Lead sponsorPhase 4Mar 2, 2015
NCT03444636Reponsible party - principal investigatorPhase 4Mar 2, 2015

Details

Founded: Warsaw, PL Mar 10, 1951
Last known activity: Aug 1, 2019